Expression of bcl-2-, p53, and Ki-67 and outcome of patients with primary nasopharyngeal carcinomas following DNA-damaging treatment. [electronic resource]
Producer: 19981118Description: 640-4 p. digitalISSN:- 1043-3074
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Apoptosis
- Carcinoma -- metabolism
- Combined Modality Therapy
- DNA Damage
- Female
- Humans
- Ki-67 Antigen -- metabolism
- Male
- Middle Aged
- Nasopharyngeal Neoplasms -- metabolism
- Neoplasm Metastasis
- Neoplasm Staging
- Prognosis
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- Survival Rate
- Tumor Suppressor Protein p53 -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.